Trial Profile
An Open-Label, Long-Term Evaluation of the Safety and Efficacy of Avanafil in Men With Erectile Dysfunction.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Dec 2021
Price :
$35
*
At a glance
- Drugs Avanafil (Primary)
- Indications Erectile dysfunction
- Focus Registrational; Therapeutic Use
- Sponsors VIVUS
- 01 Apr 2013 Results published in the International Journal of Clinical Practice.
- 05 Dec 2011 Results were presented at the 2011 European Society of Sexual Medicine Meeting
- 15 Nov 2011 Further analyses were presented at the 2011 Sexual Medicine Society of North America annual meeting, according to a VIVUS media release.